Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C39H69NO12 |
Molecular Weight | 743.9647 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 17 / 17 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]2(O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C3=C(C)C[C@@](C)(O3)[C@]([H])(O[C@@H]4O[C@H](C)C[C@@H]([C@H]4O)N(C)C(C)C)[C@H]2C
InChI
InChIKey=FPBKIOZMKHHNLL-CBUZSSJJSA-N
InChI=1S/C39H69NO12/c1-15-27-39(12,45)32(42)22(6)30-20(4)17-38(11,52-30)34(51-36-29(41)26(16-21(5)47-36)40(13)19(2)3)23(7)31(24(8)35(44)49-27)50-28-18-37(10,46-14)33(43)25(9)48-28/h19,21-29,31-34,36,41-43,45H,15-18H2,1-14H3/t21-,22+,23+,24-,25+,26+,27-,28+,29-,31+,32-,33+,34-,36+,37-,38-,39-/m1/s1
Molecular Formula | C39H69NO12 |
Molecular Weight | 743.9647 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 17 / 17 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Idremcinal (previously known as EM574), a motilin receptor agonist, has been studied for the treatment of gastritis. The drug was involved in phase II in Japan for the treatment of chronic gastritis and Gastro-esophageal reflux in the USA. However, the development of the drug was discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9535992
Thirty healthy volunteers received one of five oral doses of EM574 (IDREMCINAL) (5, 10, 20, 30 mg and placebo) in a randomized, double-blind, five-period, cross-over design; each dosing period was separated by 1-wk washout.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:00:40 GMT 2023
by
admin
on
Sat Dec 16 18:00:40 GMT 2023
|
Record UNII |
0M6189XXJN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C166426
Created by
admin on Sat Dec 16 18:00:40 GMT 2023 , Edited by admin on Sat Dec 16 18:00:40 GMT 2023
|
PRIMARY | |||
|
110480-13-2
Created by
admin on Sat Dec 16 18:00:40 GMT 2023 , Edited by admin on Sat Dec 16 18:00:40 GMT 2023
|
PRIMARY | |||
|
84019
Created by
admin on Sat Dec 16 18:00:40 GMT 2023 , Edited by admin on Sat Dec 16 18:00:40 GMT 2023
|
PRIMARY | |||
|
7837
Created by
admin on Sat Dec 16 18:00:40 GMT 2023 , Edited by admin on Sat Dec 16 18:00:40 GMT 2023
|
PRIMARY | |||
|
DTXSID10891360
Created by
admin on Sat Dec 16 18:00:40 GMT 2023 , Edited by admin on Sat Dec 16 18:00:40 GMT 2023
|
PRIMARY | |||
|
C090116
Created by
admin on Sat Dec 16 18:00:40 GMT 2023 , Edited by admin on Sat Dec 16 18:00:40 GMT 2023
|
PRIMARY | |||
|
JJ-41
Created by
admin on Sat Dec 16 18:00:40 GMT 2023 , Edited by admin on Sat Dec 16 18:00:40 GMT 2023
|
PRIMARY | |||
|
300000034232
Created by
admin on Sat Dec 16 18:00:40 GMT 2023 , Edited by admin on Sat Dec 16 18:00:40 GMT 2023
|
PRIMARY | |||
|
0M6189XXJN
Created by
admin on Sat Dec 16 18:00:40 GMT 2023 , Edited by admin on Sat Dec 16 18:00:40 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103968
Created by
admin on Sat Dec 16 18:00:40 GMT 2023 , Edited by admin on Sat Dec 16 18:00:40 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|